首页 / 专利分类库 / 有机化学 / 无环或碳环化合物 / 含有连接在同一碳架的氨基和酯化羟基的化合物
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
61 Nouveaux dérivés de benzoate d'éthanolamine, leur procédé de préparation et les compositions pharmaceutiques les renfermant EP92401620.7 1992-06-12 EP0518769B1 1994-12-07 Wierzbicki, Michel; Hugon, Pierre; Duhault, Jacques; Lacour,Françoise; Boulanger, Michelle
62 (메타)아크릴레이트계 화합물, 이를 포함하는 감광성 수지 조성물 및 이미지 센서 KR1020090046036 2009-05-26 KR1020100050375A 2010-05-13 정의준; 이창민; 김재현; 이길성; 샤로크몰탈베비; 시나마그수디
PURPOSE: A (meth)acrylate compound and a photoresist resin composition material and an image sensor including thereof are provided to manufacture the image sensor with the high definition when applying the composition to a color filter. CONSTITUTION: A (meth)acrylate compound contains a (meth)acrylate group having ester oxygen, a substituted or non-substituted anthraquinone group including transmission spectra generating red light, and a coupling element covalently bonding with the ester oxygen and the anthraquinone group. The coupling element contains a group selected form the group consisting of an alkylene group with the carbon number of 3~10, a substituted or non-substituted cycloalkylene group with the carbon number of 3~20, and a substituted or non-substituted arylene group with the carbon number of 6~30.
63 에스테르 구조를 갖는 신규 3급 아민 화합물 및 그 제조방법 KR1020020022005 2002-04-22 KR100823815B1 2008-04-21 와따나베,다께루; 하세가와,고지; 긴쇼,다께시; 하따께야마,쥰
본 발명은 화학 증폭형 포토리소그래피에 있어서, 그 첨가에 의해 해상성, 포커스 마진이 우수한 포토레지스트를 제공하는 유용한 신규 에스테르기 함유 3급 아민 화합물을 제공하는 것이다. 본 발명은 하기 화학식 1로 표시되는 에스테르기 함유 3급 아민 화합물을 제공하고 또한 그 제조 방법으로서 하기 화학식 5로 표시되는 1급 또는 2급 아민 화합물을 하기 화학식 6으로 표시되는 아크릴산에스테르 화합물에 마이클 부가 반응시키는 제조 방법, 하기 화학식 7로 표시되는 모노에탄올아민 또는 디에탄올아민을 화학식 6으로 표시되는 아크릴산에스테르 화합물에 마이클 부가 반응시켜 하기 화학식 8로 표시되는 에스테르기 함유 아민 화합물을 얻은 후, R 1 기를 도입하는 제조 방법, 하기 화학식 9로 표시되는 에스테르기 함유 3급 아민과 R 2 OH를 에스테르 교환 반응시키는 제조 방법을 제공하는 것이다. 에스테르기 함유 3급 아민 화합물, 포토레지스트, 화학 증폭형 포토리소그래피
64 폴리이미드 KR1019940035507 1994-12-21 KR100164621B1 1999-03-20 야마시타와타루; 오카와유이찌; 타마이쇼지; 마쯔오미쯔노리; 이사따쯔토므; 야마구찌케자브로; 야마구찌아키히로
본 발명은, 필수구조단위로서, 식(1) (식중, X는 직접결합, 산소원자 또는 황원자이고; R 1 , R 2 , R 3 및 R 4 는 각각 수소원자 또는 메틸기이고; Ar은 탄소수 6~27이고, 모노방향족기, 축합폴리방향족기 및 방향족기가 직접결합 또는 가교원을 통해 서로 연결될 비축합폴리방향족기로 이루어진 군에서 선택된 4가기임)로 표시된 1개이상의 반복구조단위로 이루어진 것을 특징으로 하는 비결정질 폴리이미드에 관한 것이다. 본 발명의 폴리이미드 또는 폴리이미드공중합체는 용융유동안정성이 우수하고, 성형가공성 및 내열성이 우수하므로, 구조재료, 전기·전자부품에 적용할 수 있다.
65 폴리이미드 KR1019940035507 1994-12-21 KR1019950018170A 1995-07-22 야마시타와타루; 오카와유이찌; 타마이쇼지; 마쯔오미쯔노리; 이사따쯔토므; 야마구찌케자브로; 야마구찌아키히로
본 발명은 식(1)으로 표시된 한개 혹은 그 이상의 반복구조유닛으로 구성된 필수구조유닛을 갖는 비결정질폴리이미드 혹은 폴리이미드공중합체에 관한 것이다: (식중, X는 직접결합, 산소원자 또는 황원자이고, R 1 , R 2 , R 3 , R 4 는 각각 수소원자 또는 메틸기이고 Ar은 6~27의 탄소원자를 가지며 직접결합 또는 브릿지 멤버로 서로 결합된 방향족라디칼이 있는 모노방향족라디칼, 축합폴리방향족라디칼 및 비축합폴리방향족라디칼로 구성된 그룹으로부터 선택한 4가라디칼이다) 본 발명의 폴리이미드 혹은 폴리이미드공중합체는 내열성이 뛰어나고 용융유동성이 안정하며, 매우 향상된 성형가공성을 가지고 있어 구조적재료 및 전기·전자부품분야에 응용할 수 있다.
66 EXTRACTION OF PLANT SOURCE "MEDICINAL SOUP" AND MANUAL PREPARATION OF "HERBAL MEDICINE" AND RELATED PRODUCTS EP19777982.0 2019-03-05 EP3789043A1 2021-03-10 JIANG, Chengyu; LI, Xiaoyun; DU, Jianchao; LIANG, Zhu; WANG, Zhiqing; WANG, Chenxuan

Provided is a preparation method for herbal medicine, comprising the following steps: mixing one or more lipid components and/or with any one or more of the following: nucleic acid, compounds, and macromolecules; and performing heat treatment on the obtained mixture. Also provided is a method for extracting medicinal soup from plants, comprising the following steps: using a solvent to prepare extract solution of a plant; performing differential centrifugation of the extract solution; and using an aqueous solution to re-suspend the precipitate to provide the medicinal soup.

67 APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS EP19777908.5 2019-03-28 EP3778556A1 2021-02-17 JIANG, Chengyu; LI, Xiaoyun; DU, Jianchao; LIANG, Zhu; WANG, Zhiqing; WANG, Chenxuan

The present invention relates to extracting multiple types of compounds or synthetic compounds capable of promoting nucleic acid delivery from a traditional Chinese medicine, promoting the absorption of a nucleic acid such as sRNA and the entry thereof into a target cell by using the extracted compounds or multiple combinations, and promoting the entry of the nucleic acid into a target site in an object body having such a need. The traditional Chinese medicine is selected from traditional Chinese medicine decoction pieces derived from Rhodiola rosea, Herba Taraxaci, Herba andrographitis, and Flos Lonicerae. The nucleic acid is used for treating diseases, such as heart, spleen, kidney, stomach, lung and/or bowel diseases.

68 Tetrahydronaphtalinderivate EP90104562.5 1990-03-09 EP0388739A1 1990-09-26 Hengartner, Urs, Dr.; Ramuz, Henri, Prof., Dr.

Es wurde festgestellt, dass die neuen Tetrahydronaphtha­linderivate der Formel worin R¹ bis R⁶ und n die in Anspruch 1 angegebene Bedeutung besitzen,

eine ausgeprägte der cerebralen Insuffizienz entgegen­wirkende bzw. die cognitiven Funktionen verbessernde Wirkung aufweisen und auch die Mehrfach-Resistenz gegenüber Cytosta­tika bei der Behandlung von Tumoren bzw. Chloroquinresistenz bei der Behandlung von Malaria vermindern zu mögen. Sie können demnach als Arzneimittel verwendet werden, insbeson­dere für die Bekämpfung bzw. Verhütung der cerebralen Insuffizienz bzw. für die Verbesserung cognitiver Funktionen. Die Verbindungen der Formel I können durch O-Acylierung einer ebenfalls neuen Verbindung der Formel hergestellt werden.

69 Lubrifiants et nouveaux composés polyfluorés utilisables comme additifs EP87401086.1 1987-05-14 EP0248697B1 1990-08-08 Basset, Dominique; Durual, Pierre; Fayard, Jean-Claude; Germanaud, Laurent; Hermant, Marc
70 Lubrifiants et nouveaux composés polyfluorés utilisables comme additifs EP87401086.1 1987-05-14 EP0248697A1 1987-12-09 Basset, Dominique; Durual, Pierre; Fayard, Jean-Claude; Germanaud, Laurent; Hermant, Marc

Pour améliorer les propriétés anti-usure des lubrifiants on y incorpore au moins un composé de formule : dans laquelle :

  • Rf est un radical perfluoré,
  • a = 0 à 10,
  • b = 0 ou 1 (si a = 0 et c = 1),
  • c = 1 à 4 (2 si a ≠ 0),
  • m = 0 ou 1,
  • n = 0 ou 1,
  • X est un radical aryle,
  • Y est un groupement hydroxy-2 phényl-1 éthyle,
  • R1 et R', représentent chacun un atome d'hydrogène ou un radical alkyle, cycloalkyle ou aryle,
  • R2 et R'2 représentent chacun un atome d'hydrogène ou un reste acyle, l'un au moins des symboles R1 et R2 étant autre que H ou CH3 si la somme a + m + n = Q.

71 Composés organiques d'ammonium quaternaire et procédé pour leur fabrication EP85115808.9 1985-12-11 EP0187298A2 1986-07-16 Walraevens, René; Coisne, Jean-Marc

Composés d'ammonium quaternaire, de formule générale: dans laquelle:

  • R, est un groupe alkyle ou aryle, non substitué ou substitué par au moins deux groupements ester;
  • R2, R3 et R4 sont des groupes alkyle, aryle, arylalkyle ou alkylaryle substitués par des groupements ester comportant au maximum 10 atomes de carbone;
  • m, r et n sont des nombres entiers;
  • A est un anion tel que m x r = n. Les composés sont obtenus par traitement d'une alcool-amine tertiaire avec un agent d'alkylation ou d'arylation et un agent d'acylation. Ils peuvent être utilisés comme activants des persels dans des compositions de lavage.

72 化合物或中药提取物在制备核酸递送试剂中的应用及其相关产品 PCT/CN2019/080175 2019-03-28 WO2019184991A1 2019-10-03 蒋澄宇; 李晓芸; 杜涧超; 梁竹; 王志清; 王晨轩

涉及从中药中提取多种能够促进核酸递送的化合物或合成的化合物,并利用所提取的化合物或多种组合促进核酸如sRNA吸收和进入靶细胞中,并能促进核酸进入有此需要的对象体内的靶部位;所述中药选自红景天、蒲公英、穿心莲和金花中药饮片;所述核酸用于治疗疾病,例如心脏、脾、肾、胃、和/或肠疾病。

73 NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT PCT/EP2015/067996 2015-08-04 WO2016020406A1 2016-02-11 BARTH, Roland; HÖFERL-PRANTZ, Kathrin; RICHTER, Frank; WIDSCHWENTER, Gerhard

The present invention relates to a process for the preparation of a compound of formula (Ila') and (II) Further, the present invention relates to a compound of formula (Ila') and to a compound of formula (II) as well as all intermediates prepared during the process for the preparation of compound (Ila') and compound (II).

74 NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT PCT/EP2015/067995 2015-08-04 WO2016020405A1 2016-02-11 BARTH, Roland; HÖFERL-PRANTZ, Kathrin; RICHTER, Frank; WIDSCHWENTER, Gerhard

The present invention relates to a process for the preparation of a compound of formula (A), Further, the present invention relates to the respective compound (A) as such and to its use in the preparation of antifungal agent.

75 PHARMACEUTICAL COMPOUNDS PCT/EP0007225 2000-07-27 WO0112584A3 2002-08-29 DEL SOLDATO PIERO
Compounds or their salts of general formula (I): A-B-N(O)s wherein: s is an integer equal to 1 or 2; A = R-T1-, wherein R is the drug radical and T1 = (CO)t or (X)t', wherein X = O, S, NR1c, R1c is H or a linear or branched alkyl or a free valence, t and t' are integers and equal to zero or 1, with the proviso that t = 1 when t' = 0; t = 0 when t' = 1; B = -TB -X2-O- wherein TB = (CO) when t = 0, TB = X when t' = 0, X being as above defined; X2, bivalent radical, is such that the precursor drug of A and the precursor of B meet respectively the pharmacological tests described in the description.
76 NEW FATTY ACID DERIVATIVES PCT/NO1998/000021 1998-01-23 WO98032718A1 1998-07-30
The properties of biologically active compounds, for example drugs and agrochemicals, which contain in their molecular structure one or more functional groups selected from alcohol, ether, phenyl, amino, amido, thiol, carboxylic acid and carboxylic acid ester groups are modified by replacing one or more of these functional groups by a lipophilic group selected from those of the formula: RCOO-, RCONH-, RCOS-, RCH2O-, RCH2NH-, -COOCH2R, -CONHCH2R and -SCH2R, wherein R is a lipophilic moiety selected from cis-8-heptadecenyl, trans-8-heptadecenyl, cis-10-nonadecenyl and trans-10-nonadecenyl.
77 BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS EP19789841.4 2019-09-27 EP3860561A1 2021-08-11 JAYARAMAN, Muthusamy; HE, Guo; MAIER, Martin
The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.
78 APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF EP18775996.4 2018-03-29 EP3604269A1 2020-02-05 JIANG, Chengyu; DU, Jianchao; LIANG, Zhu; LI, Xiaoyun

The present application relates to extracting, from a traditional Chinese medicine, a plurality of compounds capable of prompting nucleic acid delivery or synthetic compounds, and promoting nucleic acid such as sRNA to absorb and enter a target cell using the extracted compounds or a plurality of combinations and promoting the nucleic acid to enter required target sites in vivo of an object.

79 NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT EP15744604.8 2015-08-04 EP3177616A1 2017-06-14 BARTH, Roland; HÖFERL-PRANTZ, Kathrin; RICHTER, Frank; WIDSCHWENTER, Gerhard
The present invention relates to a process for the preparation of a compound of formula (A), Further, the present invention relates to the respective compound (A) as such and to its use in the preparation of antifungal agent.
80 Esterquats EP01125413.3 2001-10-31 EP1205470A2 2002-05-15 Bigorra Llosas, Joaquin, Dr.; Bonastre Nuria, Gilabert, Dr.; Domingo, Marta; Pi Subirana, Rafael, Dr.

Vorgeschlagen werden neue Esterquats, die man erhält, indem man Mischungen von Carbonsäuren und oxidierten Paraffinen mit Alkanolaminen und/oder Diaminen umsetzt und die resultierenden Ester bzw. Amide mit Alkylhalogeniden oder Dialkylsulfaten quaterniert.

QQ群二维码
意见反馈